Date: 2014-09-19
Type of information: Nomination
Compound:
Company: Genticel (France)
Therapeutic area:
Type agreement:
Action mechanism:
Disease:
Details: * On September 19, 2014, Genticel, a French biotechnology company and leading developer of therapeutic vaccines, announced that following the Supervisory Board’s meeting held on September 11, 2014, Mary Tanner has been appointed to the board as a new independently-acting member and as Audit Committee chairman. Mary Tanner is co-founder and senior managing director of Life Sciences Partners, LLC, a financial advisory and consulting firm that concentrates on strategy and financial advice to life sciences companies. Based in New York, Mary previously served as senior managing director for different world-renowned investment banks such as Lehman Brothers Inc, Bear Stearns and Co and Peter J. Solomon. Mary Tanner replaces a resigning board member, Amundi Private Equity Fund. Ms. Tanner is a member of the Board of Directors of Lineagen, Inc., a molecular diagnostics company. She serves on the Dean’s Council of the Yale School of Medicine and the advisory board of the Yale School of Management (US). Ms. Tanner received a B.A. from Harvard University. An American native, she is also fluent in French.
Financial terms:
Latest news:
